{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Levetiracetam", "Neuroinflammation", "streptozotocin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35098412", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "07"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "31"}], "Language": ["eng"], "ELocationID": ["10.1007/s11011-021-00888-0"], "Journal": {"ISSN": "1573-7365", "JournalIssue": {"Volume": "37", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Mar"}}, "Title": "Metabolic brain disease", "ISOAbbreviation": "Metab Brain Dis"}, "ArticleTitle": "Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer's disease.", "Pagination": {"StartPage": "689", "EndPage": "700", "MedlinePgn": "689-700"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is the most common neurodegenerative disorder among the elderly. In the light of increasing AD prevalence and lack of effective treatment, new strategies to prevent or reverse this condition are needed. Levetiracetam (LEV) is a newer antiepileptic drug that is commonly used to treat certain types of seizures. Researches indicated that LEV has several other pharmacological activities, including improvement of cognitive function. In this study, the recovery effects of chronic (28 days) administration of LEV (50, 100, and 150\u00a0mg/kg, ip) on cognitive deficits caused by the intracerebroventricular (icv) injection of streptozotocin (STZ), as a model for sporadic AD, were evaluated in rats. We also considered the protective effects of LEV against hippocampal cell loss, oxidative damage, acetylcholinesterase (AChE) activity, neuroinflammation, and tauopathy caused by STZ. LEV (100 and 150\u00a0mg/kg) significantly attenuated the STZ-induced learning and memory impairments in the passive avoidance and Morris water maze (MWM) tasks. In addition, LEV suppressed STZ-induced hippocampal neuronal loss, while restored alterations in the redox status (lipid peroxides and glutathione), AChE activity, proinflammatory cytokines (IL-1\u03b2, IL-6, TNF-\u03b1), and hyperphosphorylation of tau linked to STZ administration. In conclusion, our study demonstrated that LEV alleviated hippocampal cell death and memory deficits in STZ-AD rats, through mitigating oxidative damage, suppression of proinflammatory cytokines expression, and inhibition of abnormal tau hyperphosphorylation."], "CopyrightInformation": "\u00a9 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Alavi", "ForeName": "Mohaddeseh Sadat", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Fanoudi", "ForeName": "Sahar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Hosseini", "ForeName": "Mahmoud", "Initials": "M"}, {"Identifier": ["0000-0002-5225-8535"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. sadeghniahr@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. sadeghniahr@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sadeghniahr@mums.ac.ir."}], "LastName": "Sadeghnia", "ForeName": "Hamid R", "Initials": "HR"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Metab Brain Dis", "NlmUniqueID": "8610370", "ISSNLinking": "0885-7490"}, "ChemicalList": [{"RegistryNumber": "44YRR34555", "NameOfSubstance": "Levetiracetam"}, {"RegistryNumber": "5W494URQ81", "NameOfSubstance": "Streptozocin"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Levetiracetam"}, {"QualifierName": [], "DescriptorName": "Maze Learning"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["toxicity"], "DescriptorName": "Streptozocin"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abed El-Gaphar OAM, Abo-Youssef AM, Halal GK (2018) Levetiracetam mitigates lipopolysaccharide-induced JAK2/STAT3 and TLR4/MAPK signaling pathways activation in a rat model of adjuvant- induced arthritis. Eur J Pharmacol 826:85\u201395", "ArticleIdList": ["29501867"]}, {"Citation": "Agostinho P, Cunha RA, Oliveira C (2010) Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Curr Pharm Des 16:2766\u20132778", "ArticleIdList": ["20698820"]}, {"Citation": "Alam Q, Alam MZ, Mushtaq G, Damanhouri GA, Rasool M, Kamal MA, Haque A (2016) Inflammatory Process in Alzheimer\u2019s and Parkinson\u2019s Diseases: Central Role of Cytokines. Curr Pharm Des 22:541\u2013548", "ArticleIdList": ["26601965"]}, {"Citation": "Alrabiah H (2019) Levetiracetam. Profiles Drug Subst Excip Relat Methodol 44:167\u2013204", "ArticleIdList": ["31029217"]}, {"Citation": "Amani M, Zolghadrnasab M, Salari AA (2019) NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease. Physiol Behav 202:52\u201361", "ArticleIdList": ["30641081"]}, {"Citation": "Barilar JO, Knezovic A, Gr\u00fcnblatt E, Riederer P, Salkovic-Petrisic M (2015) Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer\u2019s disease. J Neural Transm (Vienna) 122:565\u2013576"}, {"Citation": "Barrientos RM, Kitt MM, Watkins LR, Maier SF (2015) Neuroinflammation in the normal aging hippocampus. Neuroscience 309:84\u201399", "ArticleIdList": ["25772789"]}, {"Citation": "Celikyurt IK, Ulak G, Mutlu O, Akar FY, Mulayim S, Erden F, Komsuoglu SS (2012) Positive impact of levetiracetam on emotional learning and memory in naive mice. Life Sci 90:185\u2013189", "ArticleIdList": ["22119754"]}, {"Citation": "Chen XQ, Mobley WC (2019) Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species. Front Neurosci 13:659", "ArticleIdList": ["31293377", "6598402"]}, {"Citation": "Chung HY, Sung B, Jung KJ, Zou Y, Yu BP (2006) The molecular inflammatory process in aging. Antioxid Redox Sign 8:572\u2013581"}, {"Citation": "Conway ME (2020) Alzheimer\u2019s disease: targeting the glutamatergic system. Biogerontology 21:257\u2013274", "ArticleIdList": ["32048098", "7196085"]}, {"Citation": "Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer\u2019s disease? Ageing Res Rev 10:264\u2013273", "ArticleIdList": ["21262392", "3056939"]}, {"Citation": "Detrait E, Leclercq K, L\u00f6scher W, Potschka H, Niespodziany I, Hanon E, Kaminski R, Matagne A, Lamberty Y (2010) Brivaracetam does not alter spatial learning and memory in both normal and amygdala-kindled rats. Epilepsy Res 91:74\u201383", "ArticleIdList": ["20678901"]}, {"Citation": "Devi L, Ohno M (2013) Effects of levetiracetam, an antiepileptic drug, on memory impairments associated with aging and Alzheimer\u2019s disease in mice. Neurobiol Learn Mem 102:7\u201311", "ArticleIdList": ["23416036"]}, {"Citation": "Ebada MA, Alkanj S, Ebada M, Abdelkarim AH, Diab A, Aziz MAE, Soliman AM, Fayed N, Bahbah EI, Negida A (2019) Safety and efficacy of levetiracetam for the management of levodopa- induced dyskinesia in patients with Parkinson\u2019s disease: a systematic review. CNS Neurol Disord Drug Targets 18:317\u2013325", "ArticleIdList": ["30868968"]}, {"Citation": "Ebrahimi K, Majdi A, Baghaiee B, Hosseini SH, Sadigh-Eteghad S (2017) Physical activity and beta-amyloid pathology in Alzheimer\u2019s disease: A sound mind in a sound body. Excli J 16:959\u2013972", "ArticleIdList": ["28900376", "5579405"]}, {"Citation": "El Sayed NS, Ghoneum MH (2020) Antia, a natural antioxidant product, attenuates cognitive dysfunction in Streptozotocin-induced mouse model of sporadic Alzheimer\u2019s disease by targeting the amyloidogenic, inflammatory, autophagy, and oxidative stress pathways. Oxid Med Cell Longev 2020:4386562"}, {"Citation": "El\u00e7io\u011flu H, Kabasakal L, Alan S, Salva E, Tufan F, Karan M (2013) Thalidomide attenuates learning and memory deficits induced by intracerebroventricular administration of streptozotocin in rats. Biotech Histochem 88:145\u2013152", "ArticleIdList": ["23244235"]}, {"Citation": "Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395", "ArticleIdList": ["13726518"]}, {"Citation": "Erba\u015f O, Y\u0131lmaz M, Ta\u015fk\u0131ran D (2016) Levetiracetam attenuates rotenone-induced toxicity: A rat model of Parkinson\u2019s disease. Environ Toxicol Pharmacol 42:226\u2013230", "ArticleIdList": ["26896611"]}, {"Citation": "Fanoudi S, Hosseini M, Alavi MS, Boroushaki MT, Hosseini A, Sadeghnia HR (2018) Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats. Excli J 17:999\u20131017", "ArticleIdList": ["30564080", "6295637"]}, {"Citation": "Fanoudi S, Alavi MS, Hosseini M, Sadeghnia HR (2019) Nigella sativa and thymoquinone attenuate oxidative stress and cognitive impairment following cerebral hypoperfusion in rats. Metab Brain Dis 34:1001\u20131010", "ArticleIdList": ["31016464"]}, {"Citation": "Grieb P (2016) Intracerebroventricular streptozotocin injections as a model of Alzheimer\u2019s disease: in search of a relevant mechanism. Mol Neurobiol 53:1741\u20131752", "ArticleIdList": ["25744568"]}, {"Citation": "Haghikia A, Ladage K, Hinkerohe D, Vollmar P, Heupel K, Dermietzel R, Faustmann PM (2008) Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes. J Neurosci Res 86:1781\u20131788", "ArticleIdList": ["18335543"]}, {"Citation": "Hanon E, Klitgaard H (2001) Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 10:287\u2013293", "ArticleIdList": ["11466025"]}, {"Citation": "Imai T, Sugiyama T, Iwata S, Nakamura S, Shimazawa M, Hara H (2020) Levetiracetam, an antiepileptic drug has neuroprotective effects on intracranial hemorrhage injury. Neurosci 431:25\u201333"}, {"Citation": "Inaba T, Miyamoto N, Hira K, Ueno Y, Yamashiro K, Watanabe M, Shimada Y, Hattori N, Urabe T (2019) Protective role of levetiracetam against cognitive impairment and brain white matter damage in mouse prolonged cerebral Hypoperfusion. Neuroscience 414:255\u2013264", "ArticleIdList": ["31302262"]}, {"Citation": "Itoh K, Ishihara Y, Komori R, Nochi H, Taniguchi R, Chiba Y, Ueno M, Takata-Tsuji F, Dohgu S, Kataoka Y (2016) Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice. Brain Res 1652:1\u201313", "ArticleIdList": ["27693413"]}, {"Citation": "Itoh K, Taniguchi R, Matsuo T, Oguro A, Vogel CFA, Yamazaki T, Ishihara Y (2019) Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine. Neurosci Lett 708:134363", "ArticleIdList": ["31276728"]}, {"Citation": "Kim JE, Choi HC, Song HK, Jo SM, Kim DS, Choi SY, Kim YI, Kang TC (2010) Levetiracetam inhibits interleukin-1 beta inflammatory responses in the hippocampus and piriform cortex of epileptic rats. Neurosci Lett 471:94\u201399", "ArticleIdList": ["20080147"]}, {"Citation": "Lamberty Y, Margineanu DG, Klitgaard H (2000) Absence of negative impact of levetiracetam on cognitive function and memory in normal and amygdala-kindled rats. Epilepsy Behav 1:333\u2013342", "ArticleIdList": ["12609164"]}, {"Citation": "Lamtai M, Azirar S, Zghari O, Ouakki S, El Hessni A, Mesfioui A, Ouichou A (2021) Melatonin Ameliorates Cadmium-Induced Affective and Cognitive Impairments and Hippocampal Oxidative Stress in Rat. Biol Trace Elem Res 199:1445\u20131455", "ArticleIdList": ["32613486"]}, {"Citation": "Lasierra-Cirujeda J, Coronel P, Aza M, Gimeno M (2013) Beta-amyloidolysis and glutathione in Alzheimer\u2019s disease. J Blood Med 4:31\u201338", "ArticleIdList": ["23650462", "3640603"]}, {"Citation": "Lee Y, Kim YH, Park SJ, Huh JW, Kim SH, Kim SU, Kim JS, Jeong KJ, Lee KM, Hong Y (2014) Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer\u2019s disease monkey model induced by intracerebroventricular injection of streptozotocin. J Alzheimer\u2019s Dis 38:251\u2013267"}, {"Citation": "Lyseng-Williamson KA (2011) Levetiracetam: a review of its use in epilepsy. Drugs 71:489\u2013514", "ArticleIdList": ["21395360"]}, {"Citation": "Marini H, Costa C, Passaniti M, Esposito M, Campo GM, Ientile R, Adamo EB, Marini R, Calabresi P, Altavilla D, Minutoli L, Pisani F, Squadrito F (2004) Levetiracetam protects against kainic acid-induced toxicity. Life Sci 74:1253\u20131264", "ArticleIdList": ["14697408"]}, {"Citation": "Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL (2015) Alzheimer\u2019s disease. Nat Rev Dis Primers 1:15056", "ArticleIdList": ["27188934"]}, {"Citation": "Miyazaki I, Murakami S, Torigoe N, Kitamura Y, Asanuma M (2016) Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice. J Neurochem 136:194\u2013204", "ArticleIdList": ["26485447"]}, {"Citation": "Mohammad HMF, Sami MM, Makary S, Toraih EA, Mohamed AO, El-Ghaiesh SH (2019) Neuroprotective effect of levetiracetam in mouse diabetic retinopathy: Effect on glucose transporter-1 and GAP43 expression. Life Sci 232:116588", "ArticleIdList": ["31226418"]}, {"Citation": "Moran SP, Dickerson JW, Cho HP, Xiang Z, Maksymetz J, Remke DH, Lv X, Doyle CA, Rajan DH, Niswender CM, Engers DW, Lindsley CW, Rook JM, Conn PJ (2018) M(1)-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition. Neuropsychopharmacol 43:1763\u20131771"}, {"Citation": "Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67\u201378", "ArticleIdList": ["760819"]}, {"Citation": "Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47\u201360", "ArticleIdList": ["6471907"]}, {"Citation": "Muller AP, Ferreira GK, Pires AJ, de Bem Silveira G, de Souza DL, de Abreu Brandolfi J, de Souza CT, Paula MM, Silveira PCL (2017) Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer\u2019s type. Mater Sci Eng C 77:476\u2013483"}, {"Citation": "Niu HX, Wang JZ, Wang DL, Miao JJ, Li H, Liu ZG, Yuan X, Liu W, Zhou JR (2018) The Orally Active Noncompetitive AMPAR Antagonist Perampanel Attenuates Focal Cerebral Ischemia Injury in Rats. Cell Mol Neurobiol 38:459\u2013466", "ArticleIdList": ["28401316"]}, {"Citation": "Oliveira AA, Nogueira CR, Nascimento VS, Aguiar LM, Freitas RM, Sousa FC, Viana GS, Fonteles MM (2005) Evaluation of levetiracetam effects on pilocarpine-induced seizures: cholinergic muscarinic system involvement. Neurosci Lett 385:184\u2013188", "ArticleIdList": ["15967574"]}, {"Citation": "Paula-Lima AC, De Felice FG, Brito-Moreira J, Ferreira ST (2005) Activation of GABAA receptors by taurine and muscimol blocks the neurotoxicity of \u03b2-amyloid in rat hippocampal and cortical neurons. Neuropharmacol 49:1140\u20131148"}, {"Citation": "Paxinos G, Watson C (1998) A stereotaxic atlas of the rat brain. Academic, New York"}, {"Citation": "Pilipenko V, Pupure J, Rumaks J, Beitnere U, Dzirkale Z, Skumbins R, Klusa V (2015) GABAA agonist muscimol ameliorates learning/memory deficits in streptozocin-induced Alzheimer\u2019s disease non-transgenic rat model. SpringerPlus 4:P36", "ArticleIdList": ["4797603"]}, {"Citation": "Rai S, Kamat PK, Nath C, Shukla R (2013) A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats. J Neuroimmunol 254:1\u20139", "ArticleIdList": ["23021418"]}, {"Citation": "Rajabian A, Sadeghnia HR, Hosseini A, Mousavi SH, Boroushaki MT (2020) 3-Acetyl-11-keto-\u03b2-boswellic acid attenuated oxidative glutamate toxicity in neuron-like cell lines by apoptosis inhibition. J Cell Biochem 121:1778\u20131789", "ArticleIdList": ["31642100"]}, {"Citation": "Rajasekar N, Nath C, Hanif K, Shukla R (2017) Intranasal insulin administration ameliorates streptozotocin (ICV)-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and memory impairment in rats. Mol Neurobiol 54:6507\u20136522", "ArticleIdList": ["27730514"]}, {"Citation": "Ravelli KG, dos Anjos Ros\u00e1rio B, Camarini R, Hernandes MS, Britto LR (2017) Intracerebroventricular streptozotocin as a model of Alzheimer\u2019s disease: neurochemical and behavioral characterization in mice. Neurotoxicity Res 31:327\u2013333"}, {"Citation": "Reeta KH, Mehla J, Gupta YK (2009) Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats. Brain Res 1301:52\u201360", "ArticleIdList": ["19765566"]}, {"Citation": "Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, Devidze N, Ho K, Yu G-Q, Palop JJ (2012) Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci 109:E2895\u2013E2903", "ArticleIdList": ["22869752", "3479491"]}, {"Citation": "Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555\u2013563", "ArticleIdList": ["21145918"]}, {"Citation": "Schoenberg MR, Rum RS, Osborn KE, Werz MA (2017) A randomized, double-blind, placebo\u2010controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults. Epilepsia 58:1566\u20131574", "ArticleIdList": ["28731266"]}, {"Citation": "Shannon HE, Love PL (2004) Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats. Epilepsy Behav 5:857\u2013865", "ArticleIdList": ["15582833"]}, {"Citation": "Sharma Y, Garabadu D (2020) Intracerebroventricular streptozotocin administration impairs mitochondrial calcium homeostasis and bioenergetics in memory-sensitive rat brain regions. Exp Brain Res 238:2293\u20132306", "ArticleIdList": ["32728854"]}, {"Citation": "Shi JQ, Shen W, Chen J, Wang BR, Zhong LL, Zhu YW, Zhu HQ, Zhang QQ, Zhang YD, Xu J (2011) Anti-TNF-\u03b1 reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains. Brain Res 1368:239\u2013247", "ArticleIdList": ["20971085"]}, {"Citation": "Shi JQ, Wang BR, Tian YY, Xu J, Gao L, Zhao SL, Jiang T, Xie HG, Zhang YD (2013) Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice. CNS Neurosci Ther 19:871\u2013881", "ArticleIdList": ["23889921", "6493595"]}, {"Citation": "Sola I, Aso E, Frattini D, L\u00f3pez-Gonz\u00e1lez I, Espargar\u00f3 A, Sabat\u00e9 R, Di Pietro O, Luque FJ, Clos MV, Ferrer I, Mu\u00f1oz-Torrero D (2015) Novel levetiracetam derivatives that are effective against the Alzheimer-like phenotype in mice: synthesis, in vitro, ex vivo, and in vivo efficacy studies. J Med Chem 58:6018\u20136032", "ArticleIdList": ["26181606"]}, {"Citation": "Stienen MN, Haghikia A, Dambach H, Th\u00f6ne J, Wiemann M, Gold R, Chan A, Dermietzel R, Faustmann PM, Hinkerohe D, Prochnow N (2011) Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGF\u03b21 regulation. Br J Pharmacol 162:491\u2013507", "ArticleIdList": ["20955362", "3031068"]}, {"Citation": "Stuchbury G, M\u00fcnch G (2005) Alzheimer\u2019s associated inflammation, potential drug targets and future therapies. J Neural Transm (Vienna) 112:429\u2013453"}, {"Citation": "Tan J, Paquette V, Levine M, Ensom MHH (2017) Levetiracetam clinical pharmacokinetic monitoring in pediatric patients with epilepsy. Clin Pharmacokinet 56:1267\u20131285", "ArticleIdList": ["28353057"]}, {"Citation": "Trikash I, Kasatkina L, Lykhmus O, Skok M (2020) Nicotinic acetylcholine receptors regulate clustering, fusion and acidification of the rat brain synaptic vesicles. Neurochem Int 138:104779", "ArticleIdList": ["32474177", "7256623"]}, {"Citation": "Ueda Y, Doi T, Nagatomo K, Tokumaru J, Takaki M, Willmore LJ (2007) Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection. Brain Res 1151:55\u201361", "ArticleIdList": ["17408599"]}, {"Citation": "Vafaee F, Hosseini M, Hassanzadeh Z, Edalatmanesh MA, Sadeghnia HR, Seghatoleslam M, Mousavi SM, Amani A, Shafei MN (2015) The effects of nigella sativa hydro-alcoholic extract on memory and brain tissues oxidative damage after repeated seizures in rats. Iran J Pharm Res 14:547\u2013557", "ArticleIdList": ["25901163", "4403072"]}, {"Citation": "Varoglu AO, Yildirim A, Aygul R, Gundogdu OL, Sahin YN (2010) Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance. Clin Neuropharmacol 33:155\u2013157", "ArticleIdList": ["20502135"]}, {"Citation": "Verloes R, Scotto A-M, Gobert J, W\u00fclfert E (1988) Effects of nootropic drugs in a scopolamine-induced amnesia model in mice. Psychopharmacology 95:226\u2013230", "ArticleIdList": ["3137602"]}, {"Citation": "Vogl C, Mochida S, Wolff C, Whalley BJ, Stephens GJ (2012) The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway. Mol Pharmacol 82:199\u2013208", "ArticleIdList": ["22554805"]}, {"Citation": "Wang MJ, Jiang L, Chen HS, Cheng L (2019) Levetiracetam protects against cognitive impairment of subthreshold convulsant discharge model rats by activating Protein Kinase C (PKC)-Growth-Associated Protein 43 (GAP-43)-Calmodulin-Dependent Protein Kinase (CaMK) signal transduction pathway. Med Sci Monit 25:4627\u20134638", "ArticleIdList": ["31266934", "6601366"]}, {"Citation": "Xiao R (2016) Levetiracetam might act as an efficacious drug to attenuate cognitive deficits of Alzheimer\u2019s disease. Curr Top Med Chem 16:565\u2013573", "ArticleIdList": ["26268327"]}, {"Citation": "Xu J, Gao H, Zhang L, Rong S, Yang W, Ma C, Chen M, Huang Q, Deng Q, Huang F (2019) Melatonin alleviates cognition impairment by antagonizing brain insulin resistance in aged rats fed a high-fat diet. J pineal Res 67:e12584", "ArticleIdList": ["31050371"]}, {"Citation": "Yeo HG, Lee Y, Jeon C-Y, Jeong KJ, Jin YB, Kang P, Kim SU, Kim JS, Huh JW, Kim YH (2015) Characterization of cerebral damage in a monkey model of Alzheimer\u2019s disease induced by intracerebroventricular injection of streptozotocin. J Alzheimer\u2019s Dis 46:989\u20131005"}, {"Citation": "Zou H, Brayer SW, Hurwitz M, Niyonkuru C, Fowler LE, Wagner AK (2013) Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury. Neurorehabil Neural Repair 27:878\u2013888", "ArticleIdList": ["23812605"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "22"}, {"Year": "2021", "Month": "12", "Day": "5"}, {"Year": "2022", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "31", "Hour": "6", "Minute": "6"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35098412", "10.1007/s11011-021-00888-0", "10.1007/s11011-021-00888-0"]}}], "PubmedBookArticle": []}